KLS:0101

TMC Life Sciences Berhad · KLS · Healthcare · MYR · FY for 2026

Figures on this page computed 2026-11-08 12:26 UTC

Last close

n/aMYR

Market data

42.0xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
MYR
- computed
- Computed from the filing for 2026
2.0%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
4.4%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
11.9%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.17Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
MYR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.4%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
MYR
- computed

Safety is the furthest below its sector's middle: 0.54 against 0.57 on the market's range.

All from 100

lens 2 of 9

Sales

259

2017-08-31 to 2026-06-30100 at the start259

Sales: 100.00 on 2017-08-31 to 259.06 on 2026-06-30, up 159%.

Profit

66.8

2017-08-31 to 2026-06-30100 at the start66.8

Profit: 100.00 on 2017-08-31 to 66.76 on 2026-06-30, down 33%.

Shares in issue

92.4

2017-08-31 to 2026-06-30100 at the start92.4

Shares in issue: 100.00 on 2017-08-31 to 92.39 on 2026-06-30, down 8%.

Sales is at 259, Profit is at 67, Shares in issue is at 92, against 100 in 2017.

Sales is at 259, Profit is at 67, Shares in issue is at 92, against 100 in 2017.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2026

Sales, where the first year is 100259
Source
computed
Statement
income
Fiscal year
2026
Reported in
MYR
Profit, where the first year is 10067
Source
computed
Statement
income
Fiscal year
2026
Reported in
MYR
Shares in issue, where the first year is 10092
Source
computed
Statement
income
Fiscal year
2026
Reported in
MYR